0.3848
price down icon0.21%   -0.000201
 
loading
Schlusskurs vom Vortag:
$0.385
Offen:
$0.384
24-Stunden-Volumen:
66,208
Relative Volume:
0.04
Marktkapitalisierung:
$22.68M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-41.95M
KGV:
-0.4636
EPS:
-0.83
Netto-Cashflow:
$-38.34M
1W Leistung:
+0.84%
1M Leistung:
+25.76%
6M Leistung:
-35.27%
1J Leistung:
-84.69%
1-Tages-Spanne:
Value
$0.3833
$0.385
1-Wochen-Bereich:
Value
$0.376
$0.39
52-Wochen-Spanne:
Value
$0.221
$3.28

Elevation Oncology Inc Stock (ELEV) Company Profile

Name
Firmenname
Elevation Oncology Inc
Name
Telefon
(716) 371-1125
Name
Adresse
101 FEDERAL STREET, BOSTON
Name
Mitarbeiter
34
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-05
Name
Neueste SEC-Einreichungen
Name
ELEV's Discussions on Twitter

Vergleichen Sie ELEV mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ELEV
Elevation Oncology Inc
0.3841 22.68M 0 -41.95M -38.34M -0.83
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
444.00 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
527.23 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
316.82 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
562.75 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
243.50 28.51B 3.81B -644.79M -669.77M -6.24

Elevation Oncology Inc Stock (ELEV) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-24 Herabstufung Stephens Overweight → Equal-Weight
2025-03-21 Herabstufung Citizens JMP Mkt Outperform → Mkt Perform
2025-03-21 Herabstufung Leerink Partners Outperform → Market Perform
2025-03-21 Herabstufung Piper Sandler Overweight → Neutral
2025-01-03 Eingeleitet William Blair Outperform
2024-05-31 Eingeleitet Piper Sandler Overweight
2024-05-14 Eingeleitet Stephens Overweight
2024-03-01 Eingeleitet JMP Securities Mkt Outperform
2023-05-30 Hochstufung SVB Securities Market Perform → Outperform
2021-12-23 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Elevation Oncology Inc Aktie (ELEV) Neueste Nachrichten

pulisher
Jun 17, 2025

Analyzing Ratios: Elevation Oncology Inc (ELEV)’s Financial Story Unveiled - DWinneX

Jun 17, 2025
pulisher
Jun 16, 2025

Elevation Oncology, Inc. (NASDAQ:ELEV) Sees Large Decline in Short Interest - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FLS, ELEV, MTWO, CRKN on Behalf of Shareholders - GlobeNewswire Inc.

Jun 15, 2025
pulisher
Jun 14, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 14, 2025
pulisher
Jun 13, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTCCRKN), Elevation Oncology, Inc. (NasdaqELEV), Sitio Royalties Corp. (NYSESTR), Vigil Neuroscience, Inc. (NasdaqV - TradingView

Jun 13, 2025
pulisher
Jun 13, 2025

Research Analysts Set Expectations for ELEV FY2025 Earnings - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Q2 Earnings Estimate for ELEV Issued By Leerink Partnrs - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Equities Analysts Issue Forecasts for ELEV Q3 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Wedbush Forecasts Reduced Earnings for Elevation Oncology - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Elevation Oncology (NASDAQ:ELEV) Cut to “Hold” at TD Cowen - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

HC Wainwright Downgrades Elevation Oncology (NASDAQ:ELEV) to Neutral - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Stock Rating Lowered by HC Wainwright - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Downgraded by HC Wainwright to Neutral - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Receives Market Perform Rating from JMP Securities - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Lowered to Hold Rating by William Blair - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology’s (ELEV) Neutral Rating Reaffirmed at HC Wainwright - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

ELEVATION ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Elevation Oncology, Inc.ELEV - Business Wire

Jun 10, 2025
pulisher
Jun 10, 2025

Elevation Oncology (ELEV) Receives Analyst Rating Update | ELEV Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

This McDonald's Analyst Turns Bearish; Here Are Top 4 Downgrades For Tuesday - Benzinga

Jun 10, 2025
pulisher
Jun 10, 2025

Elevation Oncology (ELEV) Receives Downgrade from HC Wainwright & Co. | ELEV Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

TD Cowen Downgrades Elevation Oncology to Hold From Buy - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

HC Wainwright Downgrades Elevation Oncology to Neutral From Buy - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Elevation Oncology (ELEV) Downgraded by H.C. Wainwright Amid Mer - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Elevation Oncology agrees to be acquired by Concentra - The Pharma Letter

Jun 10, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Acquires 41,215 Shares of Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Millennium Management LLC Boosts Stock Holdings in Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Elevation Oncology agrees to Concentra Biosciences buyout By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology (ELEV) Downgraded Following Acquisition News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology (ELEV) Downgraded by William Blair Following Acquisition Announcement | ELEV Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology (ELEV) to be Acquired by Concentra Biosciences | ELEV Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Concentra to acquire Elevation in bid to eliminate another biotech ‘zombie’ - BioPharma Dive

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology Accepts a Buyout Offer from Concentra Biosciences - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

Concentra Biosciences, LLC entered into a definitive merger agreement to acquire Elevation Oncology, Inc. for $21.4 million. - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

ELEV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Elevation Oncology, Inc. Is Fair to Shareholders - Business Wire

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology stock soars on Concentra merger agreement By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology stock soars on Concentra merger agreement - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

Concentra buys out another struggling Boston biotech - The Business Journals

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology agrees to Concentra Biosciences buyout - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology Merges with Concentra Biosciences - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology Enters into Agreement to Be Acquired by Concentra Biosciences for $0.36 in Cash per Share Plus a Contingent Value Right - PR Newswire

Jun 09, 2025
pulisher
Jun 04, 2025

Deutsche Bank AG Has $106,000 Stock Holdings in Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Purchases 59,392 Shares of Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Elevation Oncology, Inc. (NASDAQ:ELEV) Receives Average Rating of “Hold” from Analysts - Defense World

Jun 02, 2025
pulisher
May 17, 2025

Elevation Oncology Reports Q1 2025 Financial Results - TipRanks

May 17, 2025
pulisher
May 16, 2025

William Blair Remains a Buy on Elevation Oncology (ELEV) - The Globe and Mail

May 16, 2025
pulisher
May 15, 2025

Elevation Oncology Explores Strategic Alternatives - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Elevation Oncology Advances Novel HER3 ADC Program While Securing Cash Runway Through 2026 - Stock Titan

May 15, 2025
pulisher
May 15, 2025

Elevation Oncology, Inc. SEC 10-Q Report - TradingView

May 15, 2025
pulisher
May 15, 2025

Elevation Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates - PR Newswire

May 15, 2025
pulisher
May 14, 2025

Allogene's Q1 Earnings In Line With Estimates, Sales Nil - Barchart.com

May 14, 2025

Finanzdaten der Elevation Oncology Inc-Aktie (ELEV)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.42
price down icon 1.37%
$35.45
price up icon 0.65%
$21.06
price down icon 1.92%
$101.83
price down icon 0.41%
$105.86
price down icon 0.39%
biotechnology ONC
$244.00
price down icon 3.69%
Kapitalisierung:     |  Volumen (24h):